Cogent HC

Part 2 of our discussion explores the crucial role of "Hubs" in the "Network Multiplier Effect," highlighting their impact on accelerating new product adoption in medical practice. Hubs, distinct from Key Opinion Leaders (KOLs), hold significant influence through their vast networks, catalyzing transformative changes locally. Utilizing Hubs and their networks is essential for successful product launches. Discover more about harnessing this invaluable resource to fast-track your product launch.   For more insights on this topic, click here: https://lnkd.in/ea6dW2At . . #pharmaceutical #pharmaceuticallaunch #pharma #pharmaceuticalsales #healthcare #productlaunch #peernetworks #HCPnetworks #peertopeer

Accelerating the pace of product adoption in medical practice Who do you ask when you consider purchasing a new product you know little about? Do you start with a salesperson for that product or inquire among friends or experts? In Medicine, peer-to-peer interaction has always been the primary mode of learning and setting new practice standards. Click here (https://lnkd.in/e9dkDGVW) to see how impactful peer-to-peer influence is in a pharmaceutical product launch. Or join us at the PMSA conference on May 8th in Denver for a discussion of “how to ride the adoption wave to long-term brand success." . . #PMSA2024 #pharmaceutical #pharmaceuticallaunch #pharma #pharmaceuticalsales #healthcare #productlaunch #peernetworks #HCPnetworks #peertopeer

50% of Pharmaceutical Launches do not meet their first year sales expectations. It is also widely accepted that the long term trajectory of a newly launched pharmaceutical product is pretty much determined in the first 6 months.   We studied how healthcare professionals’ peer networks impact the uptake of a newly launched product. The findings are astonishing:     Using claims data that most pharma companies already own, we can identify those Communities of Practice (CoP) and local influencers (“Hubs”) that are going to be the leaders in adoption of the new product.    These CoPs had double the product adoption vs the national average by month 6 … and they never relinquished that lead, even after 6 years in our case study.    When combining faster adoption x deeper penetration (i.e., more adopters) x higher utilization (i.e., more patients per adopter), we see a multiplier effect that can reasonably result in 4 times the market share in those CoPs compared to the rest of the market … sooner!   Read more about our study of the “Network Multiplier Effect” and some of the implications for how pharma companies could adapt their go-to-market strategies to drive long term success in the first months of a product launch: https://lnkd.in/e9dkDGVW . . #pharmaceutical #pharmaceuticallaunch #pharma #pharmaceuticalsales #healthcare #productlaunch #peernetworks #HCPnetworks #peertopeer

Finding ingenious respondents is key to ensuring PRM data quality - but as so often, a single rule (time < x) is not sufficient and risks eliminating valuable responses. Another beneficial analysis is to look for consistency across answers within a single respondent.